NOVOMEDIX LLC
SAN DIEGO, CA · UEI XQYMHKGDMU75 · CAGE 4C2X1
Awarded (5-yr transactions)
$3.3M
Set-aside awards seen
1
Latest period end
Sep 2027
Largest contract awards
- 75N91025C00051$3.0M
SBIR PHASE II - ENHANCED OVERALL SURVIVAL IN HIGH-RISK PEDIATRIC SOLID TUMORS USING A NOVEL ORAL SMALL MOLECULE
National Institutes of Health · NAICS 541715 · Sep 2025 – Sep 2027 · official record ↗
- 75N91022C00001$355K
SBIR CONCEPT AWARD TO NOVOMEDIX- NOVEL SMALL MOLECULES FOR THE TREATMENT OF RHABDOMYOSARCOMA
National Institutes of Health · NAICS 541715 · Jan 2022 – Jun 2024 · official record ↗
Is this your company?
Claim it free on GovScout: matched SAM.gov opportunities for your NAICS codes, incumbent intel on every recompete, and monitoring so your SAM registration never lapses.
Claim your profile — freePublic records from FPDS (via USAspending.gov) and SAM.gov. Figures reflect harvested award data and may not be complete; verify against the linked official records. Not an endorsement. Company in the data by mistake or wish to update it? Email support@usegovscout.com.